Aleen Inc. Insights: Understanding Your Personal Wellness Patterns
Toronto, ON — December 16, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, presents a new Insight post focused on the value of noticing how personal wellness patterns evolve over time. The publication highlights why observing these subtle changes can help...
Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada
SAN DIEGO, Dec. 9, 2025 - Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed an amended registration statement on Form F-4 (the “Registration Statement”)...
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
LAS VEGAS, NEVADA, December 9, 2025 - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced a newly published study from...
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis
Toronto, ON — December 09, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, invites users to explore the philosophy behind its Wellness AI platform. From early concept testing to personal insight features, Aleen Inc. continues creating tools that help...
Aleen Inc. Advances Development of Smart Analytics Feature
Toronto, ON — December 02, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale creation of its Smart Analytics feature....
Doseology Announces Launch of Corporate Communications Program
Kelowna, BC – December 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand...
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
VANCOUVER, BC, November 19, 2025 - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the “Offering”) of 11,311,676 units of the Company (the...
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
LAS VEGAS, NEVADA, November 18, 2025 - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...
Aleen Inc. Identifies Core Insights from Concept Testing Phase
Toronto, ON — November 18, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announced the completion of its initial concept testing for the upcoming Smart Analytics feature. The research provided valuable insight into how users interact with wellness tools...
Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance
Vancouver, British Columbia – November 17, 2025 – Scope Technologies Corp. (CSE: SCPE | OTC: SCPCF | FSE: VN8) (“Scope Technologies” or the “Company”) is pleased to announce that it has successfully achieved Level 2 Certification under the CyberSecure Canada program...
Exchange News
Regulatory News
Media Relations
Public Relations
Disclosure Services